Scotland · NHS Scotland MSAN
Tolterodine 2mg and 4mg modified-release capsules
MSAN(2025)25 · Level 2 · issued 27 May 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Tolterodine 2mg and 4mg modified-release (MR) capsules are in limited supply until mid-August | Limited supply | mid-August |
| 2. Tolterodine 1mg and 2mg immediate release (IR) tablets remain available and can support | Available | — |
| 3. Alternative once-daily antimuscarinics also remain available and can support increased | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.